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Heparin-binding insulin-like growth factor 1 (HB-IGF-1) is a fusion protein of IGF-1 with the HB domain of
heparin-binding epidermal growth factor-like growth factor. A single dose of HB-IGF-1 has been shown to bind
specifically to cartilage and to promote sustained upregulation of proteoglycan synthesis in cartilage explants.
Achieving strong integration between native cartilage and tissue-engineered cartilage remains challenging. We
hypothesize that if a growth factor delivered by the tissue engineering scaffold could stimulate enhanced matrix
synthesis by both the cells within the scaffold and the adjacent native cartilage, integration could be enhanced.
In this work, we investigated methods for adsorbing HB-IGF-1 to self-assembling peptide hydrogels to deliver
the growth factor to encapsulated chondrocytes and cartilage explants cultured with growth factor-loaded
hydrogels. We tested multiple methods for adsorbing HB-IGF-1 in self-assembling peptide hydrogels, including
adsorption prior to peptide assembly, following peptide assembly, and with/without heparan sulfate (HS, a
potential linker between peptide molecules and HB-IGF-1). We found that HB-IGF-1 and HS were retained in
the peptide for all tested conditions. A subset of these conditions was then studied for their ability to stimulate
increased matrix production by gel-encapsulated chondrocytes and by chondrocytes within adjacent native
cartilage. Adsorbing HB-IGF-1 or IGF-1 prior to peptide assembly was found to stimulate increased sulfated
glycosaminoglycan per DNA and hydroxyproline content of chondrocyte-seeded hydrogels compared with
basal controls at day 10. Cartilage explants cultured adjacent to functionalized hydrogels had increased pro-
teoglycan synthesis at day 10 when HB-IGF-1 was adsorbed, but not IGF-1. We conclude that delivery of HB-
IGF-1 to focal defects in cartilage using self-assembling peptide hydrogels is a promising technique that could
aid cartilage repair via enhanced matrix production and integration with native tissue.
Introduction
Injuries to cartilage are common and have a limitedability to self-repair.1,2 One approach to enhancing the
native healing response is to deliver proanabolic growth
factors to the damaged area using a biomaterial scaffold such
that the growth factor is locally delivered at the site of injury
and in a sustained manner over time. Insulin-like growth
factor 1 (IGF-1) is known to enhance aggrecan production and
minimize aggrecan catabolism, making it an exciting candi-
date for delivery to cartilage tissue.3–5 Unfortunately, un-
modified IGF-1 has a short half-life and easily diffuses out of
the joint, creating the potential for unwanted side effects.6–8
Recently, we have shown that a fusion protein combining
the heparin-binding (HB) domain of heparin-binding epider-
mal growth factor-like growth factor (HB-EGF) and IGF-1,
called heparin-binding insulin-like growth factor 1 (HB-IGF-
1), is a promising candidate for sustained, local delivery to
cartilage. HB-IGF-1 binds to heparan sulfate (HS) with aKD of
21nMand to chondroitin sulfate with aKD of 160 nM,whereas
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IGF-1 does not bind to either.9 The mechanism of binding is
thought to be via interactions between the positively charged
HB domain of HB-IGF-1 and the negatively charged sulfated
glycosaminoglycan (sGAG) chains in cartilage. An intra-
articular injection of HB-IGF-1 into the joints of rats showed
that the growth factor bound to sGAG-containing articular
cartilage and the meniscus, but was not detected in tendon,
patella, ormuscle.9 In addition, sustained bioactivity of a single
dose of HB-IGF-1 was demonstrated by stimulation of in-
creased proteoglycan synthesis in cartilage explants 6 days
after the washout of unbound growth factor.10
Given the promising interactions between HB-IGF-1 and
cartilage tissue, we investigated severalmethods of delivering
HB-IGF-1 using the self-assembling peptide (RADA)4, or
RAD.We have found self-assembling peptide hydrogels to be
advantageous in a rabbit model of cartilage repair,11 sup-
portive of chondrogenesis for bone marrow stromal cells,12,13
and capable of delivering growth factors in vitro.14 The RAD
peptide sequence consists of alternating hydrophobic and
hydrophilic amino acids, where the hydrophilic amino acids
have alternating acidic and basic residues. Since the revers-
ible binding interaction between HB-IGF-1 and chondroi-
tin sulfate chains in cartilage is likely based on charge, we
hypothesized that we could take advantage of the charged
amino acids in RAD to bind negatively charged HS in com-
plex with HB-IGF-1, or positively charged HB-IGF-1 alone,
to deliver HB-IGF-1. We also tested adsorbing HB-IGF-1 to
RAD either before self-assembly or after the formation of the
hydrogel.
After testing these different methods of adsorbing HB-
IGF-1 to the peptide, we selected the most promising ap-
proach and tested it with chondrocyte-seeded hydrogels
and explants cocultured with functionalized hydrogels to
see whether we could stimulate proteoglycan synthesis. The
ability to deliver a proanabolic growth factor to both the
cells encapsulated in the tissue engineering scaffold and
the native cartilage tissue surrounding a cartilage defect could
be a key step in achieving integrative cartilage repair. Here,
we present work showing that adsorption of HB-IGF-1 to
RAD self-assembling peptide is a promising method for
reaching this goal.
Materials and Methods
Materials
(RADA)4 self-assembling peptide, hereafter called RAD
and also known as PuraMatrix, was a gift from 3DM (Cam-
bridge, MA). Hydrogels were formed at a concentration of
0.5% (w/v) for all experiments, consistent with previous lit-
erature.12,13,15 IGF-1 (Increlex) and HB-IGF-1 proteins were
from Ipsen/Biomeasure, Inc. (Milford, MA). Bovine joints
were from Research 87 (Marlborough, MA) and HS from
bovine kidney (0.88 sulfates/disaccharide16) was from
Sigma-Aldrich (St. Louis, MO, catalog number H7640).
Figure captions describe the number of hydrogels, explants,
or animals used in each experiment.
Cartilage explant harvest
One millimeter thick, 3mm diameter middle zone cartilage
explants were harvested from the femoropatellar grooves of 1–2
week old bovine calves and allowed to rest for 24h in basal
medium with low glucose Dulbecco’s modified Eagle’s me-
dium (Mediatech, Inc., Manassas, VA) supplemented with
penicillin, streptomycin, and amphotericin (PSA); 4-(2-
hydroxyethyl)-1-piperzaineethanesulfonic acid (Invitrogen,
Carlsbad, CA); proline (Sigma-Aldrich); ascorbate-2-phosphate
(Wake Chemicals, Richmond, VA); and non-essential amino
acids (Sigma-Aldrich), as described previously.17
Chondrocyte harvest
Cartilage from the femoral condyles of 1–2 week old
bovine calves was collected and digested with pronase for
1 h and collagenase overnight.18 Chondrocytes were filtered
from remaining tissue with cell strainers having pore sizes
of 70 and 40 mm and seeded into hydrogel culture on the
same day, as described below in the section ‘‘IGF-1 and
HB-IGF-1 delivery to peptide-encapsulated bovine chon-
drocytes.’’
14C-labeling of HB-IGF-1 and IGF-1
One percent (w/v) stock solutions of IGF-1 and HB-IGF-1
were each dialyzed overnight against 0.3M sodium phos-
phate pH 7.2 at 4C in a 2000MW cutoff cassette. A volume
of 13.4 mL of 1.25 mCi/mL [1-14C]-acetic anhydride (Amer-
ican Radiolabeled Chemicals, Inc., St. Louis, MO) dissolved
in 1,4-dioxane was added to 125 mL of each stock protein
and incubated for 30min at room temperature. The samples
were then redialyzed overnight against sodium phosphate
buffer at 4C to remove free radiolabel.
HB-IGF-1 dose–response in cartilage explants
After a 24-h rest period in basal medium, medium on the
cartilage explants was changed and replaced with new basal
medium alone, or medium containing 50 nM IGF-1, or 0.5,
5, 50, or 100 nM HB-IGF-1 for a culture period of 48 h. Fifty
nanomolar IGF-1 was chosen for the IGF-1 concentration
because it is known to be effective at stimulating an ana-
bolic response in chondrocytes and cartilage explants.3,17,19
At the end of this period, soluble growth factor was removed
by washing with phosphate-buffered saline (PBS) and re-
placed with basal medium. Medium changes with basal
medium were performed every 2 days thereafter. For the
final 24 h of culture on day 8, explants were radiolabeled
with 5 mCi/mL 35S-sulfate (Perkin Elmer, Inc., Waltham,
MA) to measure proteoglycan synthesis, as described pre-
viously.20 Unincorporated radiolabel was removed and ex-
plants were weighed wet and digested with Proteinase-K
(Roche Applied Science, Indianapolis, IN). Digested sam-
ples were analyzed for radiolabel incorporation by liquid
scintillation counting and DNA content by Hoechst dye
binding.21
HS release from acellular RAD peptide hydrogels
HS was mixed into unassembled RAD peptide solution at
a concentration of 5 mM. One hundred microliter of PBS
with PSA was layered on top of 50 mL of HS-functionalized
RAD to initiate hydrogel self-assembly.22 These volumes
were chosen to allow predicted levels of HS release from the
hydrogel to be detectable. After 15min, the bath was re-
moved and replaced with a bath of either PBS +PSA (‘‘PBS
alone’’), PBS+ PSA with 1M NaCl added (‘‘1M NaCl’’), or
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PBS + PSA with the pH adjusted to 9 with NaOH (‘‘pH 9’’).
All hydrogels were cultured at 37C. Eighty microliter of
the bath from each sample was collected and replaced every
24 h for days 1–7. The HS content of the bath was measured
by 1.9-dimethylmethylene blue (DMMB) dye binding.23
IGF-1 and HB-IGF-1 retained following adsorption
to unassembled peptide
Initial entrapment efficiency of HB-IGF-1 within the
RAD hydrogel was assessed using methods as described
previously.24 Acellular RAD was mixed with HB-IGF-1
prior to gel assembly to yield a growth factor concentration
of 50 ng/mL (4.92 mM), or a total of 2.5 mg HB-IGF-1 in
250 mg hydrogel. Fifty microliter of functionalized gel was
then cast into low-binding microcentrifuge tubes. The gels
were allowed to assemble in the tubes for 30min, after
which 500mL of PBS was layered on top of the hydrogel
samples to further induce self-assembly. The hydrogels
were stored at 37C for 3 h. As a control, 50mL of non-
functionalized RAD was prepared in the same manner. After
3 h, the PBS was sampled, and the amount of HB-IGF-1
released to PBS during the gel assembly was measured us-
ing an IGF-1 enzyme-linked immunosorbent assay (ELISA)
known to bind HB-IGF-1 (R&D Systems, catalog number
DY291). The standard curve for the ELISA was prepared
using HB-IGF-1 and PBS to match gel/PBS samples. There
was no intentional mechanical disruption of the gel. The
amount of HB-IGF-1 released from the gel into PBS was
subtracted from the amount that was initially pre-mixed into
the gel. In this way, the initial entrapment efficiency of HB-
IGF-1 was calculated.
To test growth factor retention in unassembled peptide,
50 nM IGF-1 or 50 nM HB-IGF-1 was allowed to form a
complex with 50 nM HS for 15min before mixing with
RAD peptides in solution. As additional separate conditions,
50 nM IGF-1 or 50 nM HB-IGF-1 alone were mixed with
RAD peptides in solution. Seven hundred fifty microliter of
PBS + PSA was layered on top of 50mL of hydrogel samples
to initiate self-assembly; hydrogels were then cultured at
37C in low-binding microcentrifuge tubes. These volumes
were chosen to match parallel experiments using chon-
drocyte-seeded hydrogels. The growth factor concentrations
correspond to 19 ng IGF-1 or 25 ng HB-IGF-1 being mixed
into the peptide. The bath was replaced every 24 h for 6
days. Hydrogel samples were frozen at each time point after
removal of the bath. Determination of growth factor reten-
tion was made by western blotting. Hydrogel samples were
mechanically disrupted and directly loaded into a 4–12%
Bis-Tris gel (Invitrogen) and run at 200 V for 45min. Pro-
teins were transferred to a polyvinylidine fluoride membrane
and probed with an anti-IGF-1 antibody (catalog number
9572; Abcam, Cambridge, MA), which recognizes both
IGF-1 and HB-IGF-1.10
HB-IGF-1 retained following adsorption
to preassembled peptide hydrogel
To determine the initial entrapment efficiency of HB-
IGF-1 to preassembled peptide, 50 mL of RAD hydrogel was
assembled overnight at 37C in a bath of PBS+ PSA. 14C-
HB-IGF-1 was added to the bath for a final concentration of
3.28 mM of radiolabeled protein in a bath volume of 300 mL.
Following overnight incubation at 37C, the uptake baths
were removed, and the hydrogels were gently rinsed twice
with PBS +PSA. A fresh bath of 500 mL of PBS+ PSA was
added to the hydrogel, and protein was allowed to desorb
from the hydrogel for 3 h. Following desorption, the bath was
removed from the hydrogel, and the hydrogel was mechani-
cally disrupted. Radiolabeled protein in the desorption baths
and mechanically disrupted hydrogels were measured by
liquid scintillation counting. Entrapment efficiency was de-
termined as the amount of protein remaining in the hydrogel
following the 3-h desorption, expressed as nanograms of
protein retained/micrograms of hydrogel.
To test growth factor retention in preassembled hydrogels,
50mL RAD hydrogels with or without 50 nM HS mixed in
were allowed to assemble for 24 h in 750 mL PBS +PSA at
37C in low-binding microcentrifuge tubes. After 24 h, the
bath was replaced with PBS + PSA with 50 nM HB-IGF-1,
which provides a total of 380 ng of HB-IGF-1 in the me-
dium to potentially bind to the peptide. Twenty-four hours
after addition of the HB-IGF-1 bath, soluble growth factor
was washed out of the cultures using PBS and the bath was
replaced with PBS+ PSA. Hydrogel samples were frozen
after bath removal every 24 h through day 8. Growth fac-
tor retention was assessed by western blotting, as described
above.
Release of 14C-HB-IGF-1 and 14C-IGF-1 following
adsorption to unassembled peptide
To determine a quantitative release profile, 14C-IGF-1 or
14C-HB-IGF-1 was mixed into unassembled RAD peptide
solution at a concentration of 615 nM. Thirty microliters of
PBS with PSA was layered on top of 50mL of HB-IGF-1-
or IGF-1-functionalized RAD to initiate hydrogel self-
assembly. An additional 470 mL of PBS + PSA was added to
the bath to reach a final volume of 500mL, and the hydrogels
were incubated at 37C. Two hundred fifty microliters of the
bath from each sample were collected and replaced every
24 h during days 1–8, and every 48 h between days 8 and 12.
At day 12, the baths were completely replaced with 10 ·
PBS. On day 14, the 10 · PBS baths were removed and
saved, and the hydrogels were mechanically disrupted and
saved. Radiolabeled protein in the bath and mechanically
disrupted hydrogels were measured by liquid scintillation
counting.
IGF-1 and HB-IGF-1 delivery to peptide-encapsulated
bovine chondrocytes
Bovine chondrocytes were encapsulated in RAD at a
density of 30 million cells/mL. The RAD was either unal-
tered (for ‘‘Basal,’’ ‘‘IGF soluble,’’ and ‘‘HB soluble’’
conditions), or had one of the following adsorbed to RAD
prior to cell encapsulation: 50 nM IGF-1 (for ‘‘IGF pre-
mix’’ condition) or 50 nM HB-IGF-1 (for ‘‘HB pre-mix’’
condition). See Table 1 for a summary of the culture con-
ditions. On day 0, the cell/hydrogel mixture was cast as
6mm diameter, 1.5mm thick disks into agarose rings pre-
equilibrated in the basal medium described above, as de-
scribed previously.12 Some hydrogels were cast into 50mM
tris(hydroxymethyl)aminomethane (Tris) and 1mM CaCl2
at the time of casting to measure day-0 DNA levels. The
hydrogel disks were cultured in basal medium for 24 h to
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allow peptide assembly. After 24 h, on day 1, a medium
change was performed on all hydrogels. Hydrogels for the
‘‘IGF soluble’’ and ‘‘HB soluble’’ conditions received 50 nM
IGF-1 and HB-IGF-1, respectively, in the medium through
the entire culture period. Hydrogels for the ‘‘Basal,’’ ‘‘IGF
pre-mix,’’ and ‘‘HB pre-mix’’ conditions received basal
medium for the entire culture duration. Hydrogel samples
were cultured up to 10 days with medium changes every
2 days.
For the final 24 h of culture, hydrogels were radiolabeled
with 5mCi/mL 35S-sulfate and 10 mCi/mL 3H-proline (Perkin
Elmer, Inc.) to measure proteoglycan and total protein syn-
thesis, respectively. Unincorporated radiolabel was removed
and hydrogels were weighed wet, lyophilized, weighed dry,
and digested with Proteinase-K (Roche Applied Science),
as described previously.12 Digested samples were analyzed
for radiolabel incorporation by liquid scintillation counting,
for sGAG content by DMMB dye binding,23 for DNA content
by Hoechst dye binding,21 and hydroxyproline content as a
measure of total collagen by reaction with p-dimethylami-
nobenzaldehyde.25
IGF-1 and HB-IGF-1 delivery to explants cultured
with acellular functionalized peptide
Bovine cartilage explants were harvested and placed in
basal medium to rest. One day after the harvest, 100mL
RAD hydrogels were cast into 2mL cryo-tubes and as-
sembled with 300 mL of basal medium. The hydrogel and
medium conditions, and the schedule of medium changes,
were identical to those described for the bovine chondrocyte
experiment described above. The cartilage explants received
new basal medium on day 1 and were added to the cryo-
tubes with the acellular peptide on day 2.
Explants were radiolabeled with 5 mCi/mL 35S-sulfate
(Perkin Elmer, Inc.) for the final 24 h of culture to measure
proteoglycan synthesis. Explants were washed to remove
unincorporated radiolabel, weighed wet, and digested with
Proteinase-K (Roche Applied Science). Digested samples
were analyzed for radiolabel incorporation by liquid scin-
tillation counting and DNA content was measured by
Hoechst dye binding.
Statistics
A general linear model with medium condition as an in-
dependent variable was used to analyze HB-IGF-1 dose–
response data. HS release data were rank transformed and
analyzed using a general linear model with medium condi-
tion and day as independent variables. For chondrocyte-
seeded hydrogel experiments, a one-way analysis of vari-
ance with culture condition as an independent variable was
used to analyze each time point from each of two replicate
experiments separately for sGAG per DNA, proteoglycan
synthesis, protein synthesis, and hydroxyproline content
data. Statistical symbols are those that were consistent be-
tween the two experiments. A Kolmogorov–Smirnov test
was used to test for normality and data were transformed as
necessary for all the statistical tests above. A linear mixed
model with animal as a random factor and culture condition
as an independent variable was used to analyze data from
the three functionalized hydrogel-cartilage explant coculture
experiments together. Residuals were analyzed and data
transformed as needed to ensure normality. Tukey post hoc
tests with p < 0.05 were used to evaluate statistical signifi-
cance for all pairwise comparisons. Systat 12 software
(Systat, Chicago, IL) was used for all statistical analyses.
Results
HB-IGF-1 dose–response in cartilage explants
To determine a dose of HB-IGF-1 for use in later ex-
periments, a dose–response study was first performed on
cartilage explants. Explants received medium with either
soluble IGF-1 or HB-IGF-1 at various doses for 48 h and
then unbound growth factor was removed by washing with
PBS. Six days later, explants were radiolabeled to measure
proteoglycan synthesis (Fig. 1A). Six days after removing
soluble growth factor, the 50 nM IGF-1 condition (‘‘IGF
50’’) was not statistically different from the no IGF (‘‘0’’)
control (Fig. 1B), consistent with previous reports.10 Doses
of 5, 50, and 100 nM HB-IGF-1 showed significantly greater
proteoglycan synthesis than the no IGF control and the dose
of 0.5 nM HB-IGF-1. There was a trend on increasing pro-
teoglycan synthesis as the HB-IGF-1 dose increased, al-
though 5, 50, and 100 nM HB-IGF-1 were not statistically
distinct. As the peak effect of HB-IGF-1 was seen with 50 nM
HB-IGF-1, this dose was chosen for future experiments.
HS release from acellular RAD peptide hydrogel
Because of the strong interaction between HS and HB-
IGF-1, we hypothesized that including HS in the peptide gel
could provide additional binding sites for the growth factor
and enhance the longevity of its delivery. As an initial step
toward this goal, we investigated whether HS alone could
be retained in the peptide. HS was adsorbed to unassembled
Table 1. Functionalized RAD Hydrogel and Medium Conditions for Experiments with RAD
Peptide Seeded with Bovine Chondrocytes and Cartilage Explants
Condition HB/IGF source HS
Time soluble GF
present (days)
Basal None None N/A
IGF soluble Soluble in media None 1–10
HB soluble Soluble in media None 1–10
IGF-pre-mix Adsorbed to peptides prior to gel assembly None 0
HB pre-mix Adsorbed to peptides prior to gel assembly None 0
Refer to Figure 6 for time course of experimental procedure.
HB, heparin-binding; IGF, insulin-like growth factor; HS, heparan sulfate; GF, growth factor; N/A, not applicable.
640 FLORINE ET AL.
RAD peptides in solution and cultured in a bath of either
PBS alone, PBS+ 1M NaCl (‘‘1M NaCl’’), or PBS with the
pH adjusted to 9 by NaOH (‘‘pH 9’’). Release of HS from
the peptide was measured over a 7-day period (Fig. 2). In
PBS alone, < 15% of the total HS was released from the
RAD by day 7. The addition of 1M NaCl or alteration of the
pH to 9 resulted in increased release of HS compared with
PBS alone, with the 1M NaCl bath causing more release
than the pH 9 bath.
IGF-1 and HB-IGF-1 retained following adsorption
to unassembled peptide
To test the initial entrapment efficiency of HB-IGF-1 in
unassembled peptide, 2.5 mg HB-IGF-1 was mixed with
250mg unassembled RAD and HB-IGF-1 release to the PBS
bath was measured after 3 h, similar to methods described
previously.24 We found that the RAD peptide retains*9 ng
HB-IGF-1 per microgram of peptide. We next tested whe-
ther HS improved retention of HB-IGF-1 in the peptide. To
test this, 50 nM IGF-1 or HB-IGF-1 with or without 50 nM
HS was mixed into unassembled RAD, PBS was added to
initiate assembly, and the PBS bath was then changed daily.
Each day, hydrogels were frozen after the bath was removed
and their growth factor content assessed by western blotting.
HB-IGF-1 was strongly retained in the hydrogel with or
without HS for the entire culture duration (Fig. 3A). IGF-1
was also retained for the entire culture duration with or
without HS (Fig. 3B).
HB-IGF-1 retained following adsorption
to preassembled peptide hydrogel
To test the initial entrapment efficiency of HB-IGF-1 to
preassembled hydrogels, 14C-labeled HB-IGF-1 was added
to a 300mL PBS bath at a concentration of 3.28 mM. After
24 h at 37C, the bath was removed, hydrogels were rinsed
with PBS, and a 500mL bath of fresh PBS was added. After
3 h, the amount of radiolabeled protein in the bath and the
mechanically disrupted gel were measured. About 0.57 ng of
HB-IGF-1 per microgram of peptide was retained. To in-
vestigate retention over a longer time, 50 nM HB-IGF-1 was
allowed to adsorb for 24 h to preassembled hydrogels of
RAD alone or RAD with 50 nM HS mixed in prior to as-
sembly. Soluble growth factor was then washed out of the
culture using PBS (Fig. 4A). Time points were taken daily to
assess retention of HB-IGF-1 by western blotting. HB-IGF-1
was retained in RAD (Fig. 4B) and RAD functionalized with
HS throughout the culture period (Fig. 4C). Lower levels of
FIG. 1. Heparin-binding insulin-like growth factor 1 (HB-
IGF-1) dose–response in cartilage explants at day 8 fol-
lowing wash-out procedure. (A) Timeline of experimental
procedure. Explants were treated with 50 nM IGF-1, or 0.5,
5, 50, or 100 nM HB-IGF-1 from day 0 to 2. (B) Pro-
teoglycan synthesis normalized to DNA content (mg) and the
no-growth factor (‘‘0’’) condition (dashed line) at day 8.
Values are mean – standard error of the mean (SEM). N= 6
cartilage disks per condition, one animal. Solid lines indi-
cate significant difference between two conditions, p < 0.05.
Color images available online at www.liebertpub.com/tea
FIG. 2. Heparan sulfate (HS) release from acellular pep-
tide hydrogels. Peptide with 5 mM HS cultured in 100mL
bath of phosphate-buffered saline (PBS), PBS with 1M
NaCl (‘‘1M NaCl), or PBS with a pH of 9 (adjusted using
NaOH, ‘‘pH 9’’). Values are mean – SEM. N = 6–8, except at
day 6 where n = 2. {Versus PBS alone, *versus pH 9,
p < 0.05. Color images available online at www.liebertpub
.com/tea
FIG. 3. Growth factor retention when mixed into initially
unassembled acellular peptide. Western blots of (A) HB-
IGF-1 and (B) IGF-1 retained in peptide with or without HS
on days 1 through 6, using an anti-IGF-1 antibody. Std is
a standard of 5 ng HB-IGF-1 or IGF-1 for (A) and (B),
respectively.
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protein were seen at day 8 in both conditions, perhaps
suggesting release of the adsorbed HB-IGF-1.
Based on the results in Figures 3 and 4 we concluded that
HS was not needed to retain HB-IGF-1 within the peptide
hydrogel, so these conditions were not tested in the cell-
based experiments. Furthermore, since assembling the pep-
tide prior to adsorbing the HB-IGF-1 resulted in a lower
initial entrapment efficiency and the only practical method
of delivering the growth factor in vivo using the peptide is to
mix them together prior to peptide assembly, we proceeded
with the method of mixing the growth factor into the un-
assembled peptide solution.
Release of 14C-HB-IGF-1 and 14C-IGF-1 following
adsorption to unassembled peptide
To assess the release profile of HB-IGF-1 as compared
to IGF-1, we radiolabeled both growth factors with 14C
and loaded them at a concentration of 615 nM into unas-
sembled peptide. The release to a PBS bath was measured
over the following 12 days (Fig. 5). Both growth factors
were released from the peptide hydrogel, with the 14C-IGF-1
releasing from the peptide at a faster rate than the 14C-HB-
IGF-1 over the first 4 days. Both growth factors had a slower
rate of release in the second half of the time course, with
the IGF curve approaching 100% release by day 7 and the
HB-IGF curve at 65% of the material released by day 12.
These results are consistent with the western blots shown
in Figure 3.
IGF-1 and HB-IGF-1 delivery to peptide-encapsulated
bovine chondrocytes
We next tested the ability of HB-IGF-1 adsorbed to RAD
to stimulate bovine chondrocytes encapsulated within the
peptide hydrogel. For the ‘‘HB pre-mix’’ and ‘‘IGF pre-
mix’’ conditions, 50 nM HB-IGF-1 or IGF-1, respectively,
were adsorbed to unaltered RAD prior to peptide self-
assembly and cultured in basal medium (Fig. 6). Unaltered
RAD was cultured in basal medium as a negative control
(‘‘Basal’’) or in medium containing 50 nM soluble IGF-1 or
HB-IGF-1 throughout the 10-day culture period as positive
controls (‘‘IGF soluble’’ and ‘‘HB soluble,’’ respectively).
Table 1 summarizes these peptide and medium conditions.
sGAG content normalized to DNA content was not sig-
nificantly different between any conditions at day 6 (Fig.
7A). sGAG and DNA content are individually shown in
Supplementary Figure 1 (Supplementary Data are available
online at www.liebertpub.com/tea). The soluble conditions,
HB pre-mix, and IGF pre-mix were significantly greater
than the Basal condition at day 10. HB pre-mix showed
lower proteoglycan synthesis at day 6 than the HB soluble
condition (Fig. 7B). By day 10, the soluble conditions were
significantly higher than the Basal condition. Protein syn-
thesis for HB pre-mix and IGF pre-mix were lower than IGF
soluble and HB soluble at day 6 (Fig. 7C). At day 10, the
soluble conditions exceeded the Basal condition, identical to
proteoglycan synthesis. All conditions showed increased
hydroxyproline content compared with the Basal condition
at day 6 and 10 (Fig. 7D).
IGF-1 and HB-IGF-1 delivery to explants cultured
with acellular functionalized peptide
To ensure that the growth factor adsorbed to the RAD was
bioactive and bioavailable, and also to test the hypothesis
that HB-IGF-1 could be released from the peptide to stim-
ulate nearby cartilage, we repeated the above experi-
ment with acellular functionalized peptides cocultured with
FIG. 4. HB-IGF-1 retention when adsorbed to preassem-
bled acellular peptide. (A) Time course of experimental
procedure where peptide –HS assembled from day 0 to 1
and HB-IGF-1 was absorbed to peptide from day 1 to 2.
Western blots of (B) HB-IGF-1 retained by days 3–8 after
adsorption to peptide alone, and (C) HB-IGF-1 retained by
days 3–8 after adsorption to peptide mixed with HS prior to
assembly. S is a standard of 5 ng HB-IGF-1. Two lanes for
each time point are repeats of the same condition.
FIG. 5. 14C-IGF-1 and 14C-HB-IGF-1 release from acel-
lular peptide scaffold. Peptide with 615 nM labeled growth
factor was cultured in a 500mL bath of PBS. Values are
mean – standard deviation. N= 4. Color images available
online at www.liebertpub.com/tea
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bovine cartilage explants. Explants from all conditions showed
higher proteoglycan synthesis compared with the Basal con-
dition at day 6 (Fig. 8). By day 10, the HB-IGF-1 condition
maintained increased proteoglycan synthesis levels compared
with the Basal condition. In contrast, the IGF pre-mix con-
dition showed significantly lower synthesis levels compared
with IGF soluble and was not statistically distinct from Basal
at day 10.
Discussion
We tested the hypotheses that HB-IGF-1 adsorbed to
RAD could stimulate increased sGAG accumulation in
chondrocyte-seeded hydrogels and increased proteoglycan
synthesis in cartilage explants cocultured with growth factor
functionalized hydrogels. We established a dose–response
of HB-IGF-1 and confirmed that IGF-1 does not stimulate
increased proteoglycan synthesis in cartilage explants after
washing unbound growth factor out of the culture.10 We
found that HS could be retained in RAD when added to
unassembled RAD. Since the HS was minimally released
into a bath of PBS at pH 7.4, but could be released by
increasing the pH or adding salt to the bath (Fig. 2), we
conclude that HS is retained in RAD via ionic interactions,
for example, the positively charged amino acids. Given the
strong retention of HS in RAD and the nanomolar binding
constant between HS and HB-IGF-1, we hypothesized that
HS could be used to retain HB-IGF-1 in the peptide. Be-
cause the interaction between HS and RAD was based on
charge, we also thought that positively charged HB-IGF-1
might be retained by the negatively charged amino acids in
RAD by charge interactions without the presence of HS. We
therefore pursued both of these delivery methods. HB-IGF-1
was retained in RAD with or without HS and regardless of
FIG. 6. Time course of experi-
mental procedures for bovine
chondrocytes in regular or func-
tionalized peptide hydrogels. Iden-
tical time course was used for
cartilage explants cultured with
functionalized peptide gels, where
explants were harvested at day-1,
received a media change on day 1,
and were added to gel cultures on
day 2.
FIG. 7. Extracellular matrix
content and biosynthesis by bovine
chondrocytes encapsulated within
peptide hydrogels. (A) Sulfated
glycosaminoglycan (sGAG) con-
tent normalized by DNA content,
(B) proteoglycan synthesis, (C)
protein synthesis, (D) hydroxypro-
line content, and (E) key of culture
conditions. Values are mean –
SEM. N= 5–6 · 2 experiments with
cells from different animal donors;
data from one experiment shown
above. Line indicates significant
difference between two conditions
consistent between both experi-
ments, p < 0.05. See Figure 6 for
time course of experimental pro-
cedure. Color images available
online at www.liebertpub.com/tea
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whether it was adsorbed to the peptide before or after it
was assembled. HB-IGF-1 was found to release more slowly
than untargeted IGF-1 when mixed into unassembled pep-
tide (Fig. 5).
Having established that HB-IGF-1 could be retained in
the peptide, we tested whether the growth factor could stim-
ulate cells encapsulated within the hydrogel and chon-
drocytes within adjacent cartilage explants. We found that
adsorbing HB-IGF-1 or IGF-1 to the peptide in solution,
before it was assembled, increased sGAG content normal-
ized by DNA content in chondrocyte-seeded hydrogels com-
pared with the Basal condition at day 10. Hydroxyproline
content was also enhanced compared with the Basal con-
dition at day 6 and 10. Both proteoglycan and protein syn-
thesis levels for the HB pre-mix condition were lower than
the soluble conditions at day 6, but this did not correlate
with the sGAG/DNA and hydroxyproline results. This could
be explained by a release of growth factor from the func-
tionalized peptide between the day 6 and 10 time points.
In the explant experiment (Fig. 8), there was increased
proteoglycan synthesis for explants cocultured with all
growth factor functionalized peptide conditions compared
with the Basal peptide at day 6. While IGF-1 did not provide
a sustained increase in proteoglycan synthesis in cartilage
explants compared to the basal control at day 10, the pres-
ence of a binding arm (HB-IGF-1) resulted in sustained
stimulation, analogous to results found previously where
HB-IGF-1 was delivered in the medium to cartilage ex-
plants.10 As the N-terminal tri-peptide sequence of IGF-1 is
the region associated with the IGF-1 binding to IGF-binding
proteins (IGFBPs) in native tissues,26 the addition of the HB
domain at this N-terminal region of IGF-1 may make the
HB-IGF-1 fusion protein unable to bind to IGFBPs. As a
result, it is possible that the presence of IGFBPs in cartilage
explants27 would sequester more IGF-1 than HB-IGF-1.
Interestingly, we observed that explants could be stimulated
by certain growth factor-functionalized conditions (Fig. 8)
that were not as clearly stimulatory for encapsulated chon-
drocytes in vitro (Fig. 7). We believe this may be due to the
fact that there is less extracellular GAG-rich aggrecan sur-
rounding the newly seeded chondrocytes to capture HB-
IGF-1 released by the hydrogel.
While radiolabel assays have better sensitivity than other
methods of detection, at day 12 only 65% of the radi-
olabeled HB-IGF-1 was released to the PBS bath. We at-
tempted to recover growth factor remaining in the peptide
by adding 10 · PBS and then mechanically disrupting the
gel itself to measure the remaining HB-IGF-1 directly, but
these procedures only detected an additional 10% of the
material. We hypothesize that the HB-IGF-1 is generally
more ‘‘sticky’’ due to the charged HB domain, resulting in
small losses throughout the course of the experiment that
account for the remaining material.
Ongoing studies focus on the use of radiolabeled HB-
IGF-1 to characterize transport within hydrogels and na-
tive cartilage, including diffusion and binding in space and
time. This approach may also be useful in vivo to demon-
strate release of HB-IGF-1 from the hydrogel and binding to
surrounding cartilage tissue. Additionally, in an experiment
using a similar peptide, KLD12, where the hydrogel was cast
into an annulus of cartilage tissue, 62% of the HB-IGF-1
loaded into the gel was recovered from the cartilage annulus
after 9 days in culture, whereas only 4% of the initially
loaded growth factor was recovered from the culture me-
dium. Based on the medium volume and explant-medium
geometry, these results suggest that the majority of the
growth factor diffused laterally into the cartilage rather than
being released to the medium and then adsorbed to the
cartilage. Future work also remains for understanding how
HS and HB-IGF-1 interact with unassembled and assembled
RAD fibers. Though we hypothesize that the interactions are
based on charge, the stoichiometry and how the interactions
might change as self-assembly proceeds are as yet unknown.
We note that the work presented here utilized imma-
ture bovine cartilage for explants and chondrocytes due to
availability of tissue. Confirmation of the translational value
of these results using adult bovine tissue and importantly,
mature human cartilage, would be very valuable, as im-
portant differences have been shown between cells from
different species and ages of donors.13,28–31 In the clinical
application, the peptide would likely be used to fill in a
cartilage defect following microfracture, so the cell popu-
lation would be more similar to bone marrow stromal cells
than chondrocytes.
We have shown that HB-IGF-1 adsorption to RAD self-
assembling peptide hydrogels is a promising method for
delivering the proanabolic, anticatabolic growth factor IGF-1
to cells encapsulated within hydrogels and to adjacent carti-
lage tissue. In terms of potential clinical usage, mixing HB-
IGF with peptide solution prior to hydrogel self-assembly is a
simple one step procedure for delivering a growth factor
using a hydrogel. The finding that a single dose of HB-IGF-1
mixed into the unassembled peptide at day 0 was still stim-
ulating statistically significant enhancement of proteoglycan
synthesis in adjacent cartilage explants compared with Basal
FIG. 8. Proteoglycan synthesis within cartilage explants
cultured with growth factor-functionalized acellular peptide
hydrogel. Data normalized to DNA content. Values are
mean–SEM. N= 11–12 (3–4 explants· 3 animals). Line in-
dicates significant difference between two conditions, p< 0.05.
Color images available online at www.liebertpub.com/tea
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control at day 10 demonstrates the utility of this approach
(Fig. 8). We therefore suggest that HB-IGF-1 delivered via
the peptide hydrogel to adjacent cartilage at the site of a focal
defect in vivo would be capable of binding to sGAG chains
within the cartilage and thereby enabling sustained bioactiv-
ity. The hypothesis that HB-IGF-1 would enhance the inte-
gration of peptide hydrogel-mediated neocartilage to adjacent
native cartilage at a defect interface will be tested in future
animal studies. Taken together, we believe that functionalized
self-assembling peptide hydrogels provide a promising tissue
engineering scaffold for enhancing cartilage repair.
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